Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort ascending
Apr
27
2023
Strike 1: Priority. Strike 2 :Likelihood of Confusion. Strike 3: You’re Out under Section 2(d). McDermott Will & Emery
Apr
30
2013
Obviousness-Type Double Patenting May Exist When There Is Neither Common Ownership nor Common Inventorship McDermott Will & Emery
May
5
2013
Fifth Circuit Flushes Away Pro Se Plaintiff’s Claims Against Oil Giants for Intellectual Property Theft and Infringement of a “Giant Plunger” McDermott Will & Emery
Oct
25
2018
Federal Circuit Clarifies Role of Consumer Demand in Terms of Entire Market Value McDermott Will & Emery
Oct
26
2018
Copyright Board’s Royalty Rates for Streaming Services Can Play On McDermott Will & Emery
Jun
2
2013
Large Damages OK, but Injunctive Relief Too Broad Re: Versata Software, Inc. v. SAP America, Inc. Patent Infringement Case McDermott Will & Emery
Nov
29
2018
Formula for Abstract Ideas: Alice Applied to Spreadsheet Claims with Mixed Results McDermott Will & Emery
Dec
21
2018
No Penalty: Fantasy Football Does Not Violate Players’ Right of Publicity McDermott Will & Emery
Jun
29
2013
This Flea Market Needs a Real Coach, Re: Contributory Trademark Infringement McDermott Will & Emery
Jun
30
2023
Mootness Requires Covenant Not to Sue to Be Unconditional and Irrevocable McDermott Will & Emery
Jan
29
2016
Repeated Disparagement of the Prior Art in the Specification Can Operate as a Clear and Unmistakable Disavowal of Claim Scope McDermott Will & Emery
Jan
29
2016
IPR Survives Despite Petitioner Failure to Name All Real Parties of Interest McDermott Will & Emery
Jan
30
2019
Second Circuit: No First Sale Doctrine for Reproduced Digital Files McDermott Will & Emery
Jul
13
2023
Coons and Tillis Introduce Two Bills Intended to Change Patent Landscape McDermott Will & Emery
Aug
1
2013
“Reverse Payment” Settlements Face Greater Antitrust Scrutiny Following U.S. Supreme Court Ruling in FTC v. Actavis McDermott Will & Emery
Aug
4
2013
Course of Conduct Does Not Supplant Unambiguous Terms of an Non-Disclosure Agreement (NDA) McDermott Will & Emery
Feb
28
2019
No Parking: Source of Anticipating Disclosure Determines if it's "Of Another” McDermott Will & Emery
Mar
6
2019
“Full Costs” Under the Copyright Act Means Those Costs Specified iIn General Costs Statute McDermott Will & Emery
Aug
30
2013
Default Judgment Affirmed Against Imposter Re: Trademark Litigation McDermott Will & Emery
Aug
31
2023
No Two Ways About It: No Disparagement ≠ Teaching Away, Free Samples ≠ Commercial Success McDermott Will & Emery
Feb
25
2016
Pfizer, Inc. v. Lee: Time Between Original and Corrected Restriction Requirement Nets No Further Patent Term Adjustment McDermott Will & Emery
Mar
29
2019
“Full Costs" Under Copyright Act Means Those Specified in General Costs Statute McDermott Will & Emery
Sep
21
2023
Tragic Ending: Award-Winning AI Artwork Refused Copyright Registration McDermott Will & Emery
Sep
28
2023
What’s Kühler Than Kühl? No Likelihood of Confusion McDermott Will & Emery
Apr
26
2019
A Window into PTAB Derivation Proceedings McDermott Will & Emery
Oct
5
2023
Beware Enablement of Genus Antibody Claims McDermott Will & Emery
May
23
2019
U.S. Supreme Court | Rejection Of A Trademark License In Bankruptcy Is A Breach Of Contract That Does Not Terminate The Licensee’s Right To Use The Mark McDermott Will & Emery
May
30
2019
Case Law Beats PTO Guidance On Patent Eligibility McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins